Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST

Lifecare ASA will publish its Q2 2026 results on Wednesday, 19 August 2026, at 07:00 CEST.

The company invites shareholders, investors, and other stakeholders to the presentation of the second quarter results the same day at 08.45 CEST, to be held at Scandic Flesland Airport Hotel, Bergen, Norway, in connection with the event Vestland på Børs.

The results will be presented in English via a live webcast, followed by a Q&A session. Participants will be able to submit questions online throughout the webcast.

The webcast will be available at https://lifecare.no/investor/reports-presentations/ and can also be accessed directly here (https://qcnl.tv/p/cs5yp_qSoQuYbeLPKsfJkA).

A recording of the webcast will be made available on our website shortly after the event.

About us

Lifecare ASA is a medical sensor company developing technology for sensing and monitoring of various body analytes. Lifecare's focus is to bring the next generation of Continuous Glucose Monitoring systems to market. Lifecare enables osmotic pressure as sensing principle. Lifecare's sensor technology is suitable for identifying and monitoring the occurrence of a wide range of analytes and molecules in the human body and in pets.

Contacts

For further information, please contact:

Joacim Holter, CEO, joacim.holter@lifecare.no, +47 40 05 90 40 Petter Nielsen, CFO, petter.nielsen@lifecare.no, +47 92 24 74 64